Emergent BioSolutions Inc. (EBS) dividend history

EBSNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3072% below fair value

$5.79−0.10 (-1.70%)

Close on Nov 13, 2026Market cap $296.87MP/E –Yield –

Dividends

No dividend per share appears in Emergent BioSolutions's annual filings since fiscal 2010.

Parsed from the XBRL in Emergent BioSolutions's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EBS.

Revenue growth-17.7% · median 4.1%

Gross margin48.4% · median 54.5%

Operating margin-27.7% · median 7.9%

Net margin-40.2% · median -2.4%

Advertisement
300 × 250

See a number that looks wrong?